Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04033562 · ClinicalTrials.gov registry record · Phase 4
The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis
A Phase 4 study, sponsored by WellSpan Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT04033562: Clinical Trial Phase 4 study, sponsored by WellSpan Health.
NCT04033562 is a Phase 4 study that was terminated before completion, run by WellSpan Health. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04033562, a Phase 4 study, was terminated before completion, sponsored by WellSpan Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
Pregnant women with a history of opioid use disorder, chronic opioid use or those who are on medication assisted treatment will be randomly assigned to receive either a sub-fascial continuous infusion of bupivacaine or lidocaine/menthol patch after Cesarean delivery. Post-operative pain scores and opioid usage in the post-operative period will be recorded.
Primary Outcome
Post-operative pain scores using the visual analog scale (a scale that measures pain in 1 unit increments on a scale 0-10 with 0 being "no pain at all" and 10 being "the worst pain imaginable"
Interventions
- DRUG Lidocaine patch
- DEVICE Ambu ACTion pump, 0.125% bupivacaine at 8cc/hr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2021-05-17 |
| Phase | Phase 4 |
Why NCT04033562 stopped before completion
NCT04033562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Lidocaine patch is the first listed.
NCT04033562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04033562 about?
NCT04033562 is a clinical study titled "The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis". Pregnant women with a history of opioid use disorder, chronic opioid use or those who are on medication assisted treatment will be randomly assigned to receive either a sub-fascial continuous infusion of bupivacaine or lidocaine/menthol patch after Cesarean delivery. Post-operative pain scores and o...
What is the current status of trial NCT04033562?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2020-01-15. Estimated completion is 2021-05-17.
What interventions are being tested in trial NCT04033562?
The interventions under investigation include: Lidocaine patch (DRUG), Ambu ACTion pump, 0.125% bupivacaine at 8cc/hr (DEVICE).
Who is sponsoring clinical trial NCT04033562?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04033562's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI